Cargando…
A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment
Autism spectrum disorder (ASD) is a neurodevelopmental condition impacting behavior, communication, social interaction and learning abilities. Medical cannabis (MC) treatment can reduce clinical symptoms in individuals with ASD. Cannabis-responsive biomarkers are metabolites found in saliva that cha...
Autores principales: | Quillet, Jean-Christophe, Siani-Rose, Michael, McKee, Robert, Goldstein, Bonni, Taylor, Myiesha, Kurek, Itzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444802/ https://www.ncbi.nlm.nih.gov/pubmed/37608004 http://dx.doi.org/10.1038/s41598-023-40073-0 |
Ejemplares similares
-
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
por: Siani-Rose, Michael, et al.
Publicado: (2023) -
Metabolomic Signatures of Autism Spectrum Disorder
por: Brister, Danielle, et al.
Publicado: (2022) -
Safety and Efficacy of Cannabis in Autism Spectrum Disorder
por: Ganesh, Abhinaya, et al.
Publicado: (2020) -
Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
por: Agarwal, Rumi, et al.
Publicado: (2019) -
Cannabis and cannabinoid use in autism spectrum disorder: a systematic review
por: da Silva, Estácio Amaro, et al.
Publicado: (2021)